Nevertheless, given the numerous activities carried out by this apolipoprotein, including neuroprotective and pathogenic mechanisms, it should not to be considered as a traditional therapeutic target, and further studies need to be carried out to explore novel potential apoJ-based therapeutic strategies in AD. The gene discussed is CLU; the disease is Alzheimer disease.